[
    "sitions, wherein said compositions comprises contraceptive and formula (I) or (Ia) CB1 receptor inverse-agonist or agonist compounds, and wherein said compositions reduces the impulsion of patient's smoking and/or helps the patient to reduce body weight.</p>The present invention includes the Cannibinoid receptor modulators that is used for the treatment of, alleviates or prevent the receptor-mediated syndrome of CB, disorder or disease.The compounds of this invention or its compositions can method disclosed according to the present invention be measured as the effectiveness of CB regulator.The scope of these purposes comprises treatment, alleviates or prevents the receptor-mediated syndrome of most CB, disorder or disease.</p>The invention still further relates to a kind of treatment in the patient who needs is arranged, alleviate or the method for the receptor-mediated syndrome of prevention CB, disorder or disease, wherein said syndrome, disorder or disease relate to appetite, metabolism, diabetes, intraocular pressure, social activity and affective disorder, epilepsy, substance abuse, study, cognition or memory, organ contraction or muscle spasm, enteropathy, respiratory disorder, ability to act or the dyskinesia, immunity and inflammatory diseases that glaucoma is relevant, dysregulated cellular growth, pain therapy, neuroprotective etc.</p>As the formula (I) of CB receptor modulators or (Ia) chemical compound comprise that the CB receptor-binding activity is had average inhibition constant (IC\n          <sub>50</sub>) chemical compound between following each scope: about 50 \u03bc M are to about 0.01nM; About 25 \u03bc M are to about 0.01nM; About 15 \u03bc M are to about 0.01nM; About 10 \u03bc M are to about 0.01nM; About 1 \u03bc M is to about 0.01nM; About 800nM is to about 0.01nM; About 200nM is to about 0.01nM; About 100nM is to about 0.01nM; About 80nM is to about 0.01nM; About 20nM is to about 0.01nM; About 10nM is to about 0.1nM; Or about 0.1nM.\n        </p>As the formula (I) of CB receptor modulators of the present invention or (Ia) chemical compound comprise the CB1 agonist in conjunction with active CB1 agonist IC\n          <sub>50</sub>Chemical compound between following each scope: about 50 \u03bc M are to about 0.01nM; About 25 \u03bc M are to about 0.01nM; About 15 \u03bc M are to about 0.01nM; About 10 \u03bc M are to about 0.01nM; About 1 \u03bc M is to about 0.01nM; About 800nM is to about 0.01nM; About 200nM is to about 0.01nM; About 100nM is to about 0.01nM; About 80nM is to about 0.01nM; About 20nM is to about 0.01nM; About 10nM is to about 0.1nM; Or about 0.1nM.\n        </p>As the formula (I) of CB receptor modulators of the present invention or (Ia) chemical compound comprise the CB1 antagonist in conjunction with active CB1 antagonist IC\n          <sub>50</sub>Chemical compound between following each scope: about 50 \u03bc M are to about 0.01nM; About 25 \u03bc M are to about 0.01nM; About 15 \u03bc M are to about 0.01nM; About 10 \u03bc M are to about 0.01nM; About 1 \u03bc M is to about 0"
]